1,203 results on '"Jalan, R"'
Search Results
2. Intensive care management of acute-on-chronic liver failure
3. Knowledge Attitude And Practice Of Disinfection Of Gutta Percha Among Post Graduate Dental Students
4. Effect Of Parental Involvement In The Academic Performance Of The Children- A Survey
5. SIRS, Bacterial Infections, and Alterations of the Immune System
6. Imaging of the hip and groin
7. Editorial: proton pump inhibitor therapy and liver disease progression—more cause for concern?
8. Editorial: alfapump—an alternative to large‐volume paracentesis for patients with refractory ascites?
9. Hypothermia for the management of intracranial hypertension in acute liver failure
10. Molecular Adsorbents Recirculating System (MARS) for acute decompensation of chronic liver disease: an early clinical experience
11. Increased cerebral and peripheral vasodilation, and whole body nitric oxide production after insertion of a transjugular intrahepatic portal-systemic stent in patients with cirrhosis
12. Metabolic consequences of an upper gastro-intestinal bleed in patients with cirrhosis
13. Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe
14. Letter to the Editor - Reply to 'Ammonia - an old friend with a new area of application
15. Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis
16. Anti-Inflammatory Activity of Boerhavia diffusa Zinc Oxide Nanoparticle
17. Editorial: obesity in chronic liver diseases – increased infections; authorsʼ reply
18. Obesity is independently associated with infection in hospitalised patients with end-stage liver disease
19. PTH-095 Oral carbon therapy is associated with a selective modulation of the microbiome in cirrhotic rats which is associated with a significant reduction in inflammatory activation
20. PWE-141 Alfa pump for the treatment of refractory ascites: a “real world” experience from the uk
21. PWE-115 Acute decompensation of cirrhosis requiring hospitalisation is not reversible and defines future organ specific decompensation
22. PWE-099 Porto-systemic shunt embolization and recurrent ascites: a single centre case series
23. PWE-094 Monitoring heart rate variability during acute decompensation predicts mortality and risk of recurrent hospitalisation
24. PWE-098 Increase in gut permeability is an early event in cirrhosis and is not associated with bacterial translocation, systemic inflammation or clinical features: a prospective longitudinal study
25. Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit
26. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS)
27. OC-035 Lifetouch®: A Novel Remote Monitoring Device to Identify Patients with Advanced Cirrhosis Most at Risk of Decompensation – a Proof of Concept Study
28. Role of artificial liver support in hepatic encephalopathy
29. Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis
30. The treatment of hepatic encephalopathy
31. Role of ammonia and inflammation in minimal hepatic encephalopathy
32. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF (vol 72, pg 688, 2020)
33. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease
34. The analysis of acetaminophen (paracetamol) and 7 metabolites in rat, pig and human plasma by U(H)PLC-MS
35. l-Ornithine phenylacetate (OP): A novel treatment for hyperammonemia and hepatic encephalopathy
36. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation
37. Ammonia and Hepatic Encephalopathy: The More Things Change, the More They Remain the Same
38. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia
39. Prospects for extracorporeal liver support
40. Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding
41. Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis
42. Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver. (Liver)
43. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. (Liver Disease)
44. SIRS, Bacterial Infections, and Alterations of the Immune System
45. Dogs with congenital porto-systemic shunting (cPSS) and hepatic encephalopathy have higher serum concentrations of C-reactive protein than asymptomatic dogs with cPSS
46. OC-066 Toll like receptor 4 antagonist prevents acetaminophen induced acute liver failure in mice: a novel therapeutic strategy
47. OC-068 Albumin is central in mediating the cardio-renal dysfunction of cirrhosis: a study in analbuminaemic rats
48. OC-023 Extracorporeal liver support using UCL-arsenel reduces inflammation, improves haemodynamic function and increase survival time in a porcine paracetamol-induced acute liver failure model
49. Overnight glucose infusion suppresses renal ammoniagenesis and reduces hyperammonaemia induced by a simulated bleed in cirrhotic patients
50. ‘Out-patient’ albumin dialysis for cholestatic patients with intractable pruritus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.